Bailard Inc. bought a new stake in Colony Bankcorp, Inc. (NASDAQ:CBAN - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 16,451 shares of the financial services provider's stock, valued at approximately $266,000. Bailard Inc. owned approximately 0.09% of Colony Bankcorp as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors have also recently bought and sold shares of CBAN. SG Americas Securities LLC acquired a new position in shares of Colony Bankcorp during the 4th quarter worth approximately $113,000. Fiduciary Alliance LLC acquired a new position in shares of Colony Bankcorp during the 4th quarter worth approximately $239,000. JPMorgan Chase & Co. increased its position in shares of Colony Bankcorp by 137.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 28,103 shares of the financial services provider's stock worth $436,000 after purchasing an additional 16,246 shares during the last quarter. Empowered Funds LLC increased its position in shares of Colony Bankcorp by 5.2% during the 3rd quarter. Empowered Funds LLC now owns 35,478 shares of the financial services provider's stock worth $551,000 after purchasing an additional 1,742 shares during the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. increased its position in shares of Colony Bankcorp by 116.1% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 37,285 shares of the financial services provider's stock worth $579,000 after purchasing an additional 20,031 shares during the last quarter. Institutional investors own 50.37% of the company's stock.
Colony Bankcorp Stock Performance
Shares of CBAN stock traded up $0.05 during trading on Friday, reaching $16.31. 124,125 shares of the company's stock were exchanged, compared to its average volume of 68,787. The company has a quick ratio of 0.80, a current ratio of 0.81 and a debt-to-equity ratio of 0.90. The stock has a market capitalization of $285.75 million, a PE ratio of 12.08 and a beta of 0.63. Colony Bankcorp, Inc. has a twelve month low of $10.33 and a twelve month high of $18.49. The firm's fifty day moving average price is $16.47 and its 200-day moving average price is $16.14.
Colony Bankcorp Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Wednesday, February 19th. Investors of record on Wednesday, February 5th were issued a dividend of $0.115 per share. The ex-dividend date was Wednesday, February 5th. This is a positive change from Colony Bankcorp's previous quarterly dividend of $0.11. This represents a $0.46 dividend on an annualized basis and a dividend yield of 2.82%. Colony Bankcorp's payout ratio is presently 34.07%.
Analyst Ratings Changes
Separately, StockNews.com raised Colony Bankcorp from a "hold" rating to a "buy" rating in a research report on Thursday, January 9th.
Get Our Latest Stock Report on CBAN
About Colony Bankcorp
(
Free Report)
Colony Bankcorp, Inc operates as the bank holding company for Colony Bank that provides various banking products and services to commercial and consumer customers. The company offers deposit products, including demand, savings, and time deposits. It also provides loans to small and medium-sized businesses; residential and commercial construction, and land development loans; commercial real estate loans; commercial loans; agri-business and production loans; residential mortgage loans; home equity loans; and consumer loans.
Recommended Stories
Before you consider Colony Bankcorp, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Colony Bankcorp wasn't on the list.
While Colony Bankcorp currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
